Side Effects: See also Warning section.Diarrhea, dizziness, drowsiness, hair loss, blurred/double vision, change in menstrual periods, ringing in the ears, shakiness (tremor), unsteadiness, weight changes may occur. If any of these effects persist or worsen ...
This series of technical supplements has been written to amplify the recommendations given in Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products (WHO Technical Report Series, No. 961, 2011, Annex 9).
for X12N 007030â¢ Technical Reports. X12's Insurance Subcommittee (X12N) has revised the schedule for public review and comment periods related to the 007030 counterparts to the HIPAA-adopted transactions and related Type 3 Technical Reports (TR3s).